How common is PMDD worldwide?

PMDD prevalence worldwide varies by how the diagnosis was made:

• 3.2% confirmed through two cycles of daily symptom tracking, across more than 50,000 participants in a 2024 meta-analysis (Reilly et al., Journal of Affective Disorders) [2]
• 7.7% on a provisional diagnosis, based on a single questionnaire or interview rather than prospective daily ratings [2]
• 1.6% confirmed diagnosis in community studies specifically (Reilly et al., 2024) [2]

PMDD is a DSM-5-TR diagnosis (and ICD-11 code GA34.41), distinct from PMS, which is common and doesn't require the same symptom count or daily tracking to confirm.

The gap between the confirmed and provisional figures matters more than either number alone:

• A provisional diagnosis catches more people who report symptoms on a single questionnaire or interview
• Some of those people won't still meet criteria once their symptoms are tracked day by day across a cycle
• The 3.2% figure is the one to reach for when you need a single global estimate

For a fuller breakdown of what goes into that number, see how common PMDD is.

The largest and most rigorous estimate comes from a 2024 meta-analysis pooling 50,659 participants across 48 independent samples in 44 studies, using a random-effects model [2]. It found confirmed PMDD prevalence of 3.2%, with a wide confidence interval (1.7% to 5.9%) because the underlying studies varied enormously in population and method.

Regional reviews add detail the global figure can't capture on its own. A systematic review of women in India (25 studies, 8,542 participants total) pooled the 11 studies that reported PMDD specifically and found a prevalence of 8% [1]. A 2025 review of 5,131 nursing students across several countries found 21%, though that figure folds severe PMS in alongside PMDD rather than counting PMDD alone [6].

A separate global protocol, registered in 2022, set out to map PMDD prevalence region by region using both English and Chinese-language databases; results from that effort haven't been published yet [3]. Until they are, the 2024 meta-analysis remains the best single global reference, and the research library tracks what's published since.

PMDD prevalence looks very different depending on who's studied and how old they are.

Adolescents and students consistently show the highest numbers. The Ethiopian review found a pooled PMDD prevalence of 54.5% among high school and university students, with a confidence interval running from 40.8% to 67.6% [4]. That's far above the global confirmed estimate, and it likely reflects both real vulnerability at younger ages and a diagnostic approach that skipped prospective daily ratings.

Among elite athletes, confirmed PMDD prevalence ranged from 1.3% to 13.1% across seven studies, with no statistically significant difference from non-athletes, suggesting intense training alone doesn't drive the condition higher [5].

In the same India review, overall PMS prevalence came in at 43%, compared with 8% for PMDD specifically [1]. That gap matches the broader, global pattern: PMS is common, and PMDD is a smaller, more severe subset of it. For how that split plays out globally, see how common PMS is.

A handful of factors explain most of the spread between a 1.6% confirmed estimate and a 54.5% estimate in one adolescent population.

• Diagnostic method. Confirmed diagnosis requires two cycles of daily symptom ratings. Provisional diagnosis relies on a single questionnaire or interview and tends to run two to three times higher [2].
• Who's studied. General population samples, nursing students, athletes and adolescents carry different baseline stress, sleep and health demands.
• Age. Adolescent and student samples report higher rates than adult community samples, though researchers haven't settled on why.
• Study heterogeneity. The 2024 global meta-analysis found I² of 99% between studies, meaning almost all the variation is real difference between studies, not chance [2].
• Screening tool and threshold. Different reviews use different symptom checklists and cutoffs for what counts as functional impairment.

None of this means the numbers are unreliable. It means a single global percentage can't describe every population, and the method behind a number matters as much as the number itself. To understand what the diagnosis actually requires, see what causes PMDD and how it gets confirmed.

Whatever the exact percentage in your country or age group, the pattern that matters is the same: about 3 in 100 women and girls worldwide live with confirmed PMDD, and the figure in a group like yours could run higher [2].

If your mood symptoms show up mainly in the week before your period, ease within a few days of it starting, and stay minimal the rest of the month, that pattern fits PMDD. It doesn't mean you have it. Only two cycles of daily tracking and a clinician's assessment can confirm that, and how PMDD gets diagnosed often takes longer than it should.

Niyora is a PMS and PMDD support app. If you want to start noticing whether your premenstrual days cluster the same way the research describes, Niyora's Moon lets you write down what happened, see it from another angle and calm down before you decide what to say.